Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome-Reference-Cited by-同舟云学术

Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome

Published:2016-09-06 Issue:12 Volume:95 Page:2023-2031
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Jia Jing,Song Yuqin,Lin Ningjing,Liu Weiping,Ping Lingyan,Zheng Wen,Wang Xiaopei,Xie Yan,Tu Meifeng,Zhang Chen,Ying Zhitao,Deng Lijuan,Ding Ning,Zhu Jun

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-016-2805-9.pdf

Reference44 articles.

1. Chan JK, Ng CS (1989) Malignant lymphoma, natural killer cells and hemophagocytic syndrome. Pathology 21:154–155

2. Okuda T, Sakamoto S, Deguchi T et al (1991) Hemophagocytic syndrome associated with aggressive natural killer cell leukemia. Am J Hematol 38:321–323

3. Wong KF, Chan JK, Ng CS, Chu YC, Li LP, Chan CH (1992) Large cell lymphoma with initial presentation in the bone marrow. Hematol Oncol 10:261–271

4. Filipovich AH (2009) Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program 1:127–131

5. Kumakura S (2005) Hemophagocytic syndrome. Intern Med 44:278–280

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical epidemiology of Epstein-Barr virus-associated Lymphoproliferative Disorders (EBV-LPDs) in hospitalized children: A six-year multi-institutional study in China;Italian Journal of Pediatrics;2024-07-02

2. Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis;Journal of Hematology;2024-04

3. Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis;Leukemia;2024-01-18

4. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS);Annals of the Rheumatic Diseases;2023-07-24

5. The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS);Arthritis & Rheumatology;2023-07-24